Ticker League

TTM

23.7%

YoY change

+4.90pp

Trough year (2021)

2.8%

Peak year (2011)

38.1%

Operating Margin history chart for AstraZeneca (AZN) from 1990 to 2025

Latest: 23.4%

Operating Margin change chart for AstraZeneca (AZN) from 1990 to 2025

Latest: +4.90pp

Operating Margin history table for AstraZeneca (AZN) from 1990 to 2025

  • 202523.4%+4.90pp
  • 202418.5%+0.61pp
  • 202317.9%+9.41pp
  • 20228.5%+5.65pp
  • 20212.8%-16.57pp
  • 202019.4%+7.40pp
  • 201912.0%-3.34pp
  • 201815.3%-1.03pp
  • 201716.4%-4.94pp
  • 201621.3%+4.66pp
  • 201516.7%+8.60pp
  • 20148.0%-6.33pp
  • 201314.4%-14.74pp
  • 201229.1%-8.96pp
  • 201138.1%+3.54pp
  • 201034.5%-0.64pp
  • 200935.2%+6.25pp
  • 200828.9%+1.55pp
  • 200727.4%-3.65pp
  • 200631.0%+3.88pp
  • 200527.1%+5.93pp
  • 200421.2%-0.04pp
  • 200321.3%-1.20pp
  • 200222.5%-2.76pp
  • 200125.2%+4.99pp
  • 200020.2%-2.43pp
  • 199922.7%+1.22pp
  • 199821.4%+0.59pp
  • 199720.9%+1.40pp
  • 199619.4%+2.52pp
  • 199516.9%+2.22pp
  • 199414.7%-1.15pp
  • 199315.9%+8.74pp
  • 19927.1%-10.25pp
  • 199117.4%+1.61pp
  • 199015.7%

Operating Margin values are taken from AstraZeneca's reported income statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Margin at AstraZeneca (AZN)

According to AstraZeneca's latest reported financial statements, the company's latest reported operating margin is 23.7%. Operating margin is operating income divided by revenue — the share of each sales dollar left after cost of goods sold and operating expenses (SG&A, R&D), but before interest and taxes. It isolates how profitable the core business is before financing and tax decisions, so it is comparable across companies with different capital structures.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of AstraZeneca (AZN) operating margin is 23.40% – expanded 4.9 percentage points year-over-year.

The record annual operating margin stands at 38.09%, reached in 2011; the historical low of 2.82% was recorded in 2021.

AstraZeneca Operating Margin by Year

AstraZeneca Operating Margin 2025: 23.4%

AstraZeneca operating margin in 2025 was 23.40%, expanded 4.9 percentage points from 2024.

AstraZeneca Operating Margin 2024: 18.5%

2024's operating margin for AstraZeneca came in at 18.50%, expanded 0.6 percentage points from 2023.

AstraZeneca Operating Margin 2023: 17.9%

AstraZeneca posted operating margin of 17.88% in 2023, expanded 9.4 percentage points from 2022.

AstraZeneca Operating Margin 2022: 8.5%

In 2022, AstraZeneca reported operating margin of 8.47%, expanded 5.6 percentage points from 2021.

AstraZeneca Operating Margin 2021: 2.8%

AstraZeneca operating margin in 2021 was 2.82%.

See more financial history for AstraZeneca (AZN).

Sector peers by Operating Margin

Healthcare peers of AstraZeneca (AZN), ranked by their latest operating margin

Frequently asked questions